Beth Israel Lahey Health

Beth Israel Lahey Health (BILH) operates as the largest integrated health system in Massachusetts. It brings together academic medical centers and teaching hospitals with community and specialty hospitals. The organization has significant translational research hubs in oncology, cardiovascular/metabolic diseases, inflammatory/infectious diseases and neurology. Its investigators have contributed to major medical advances such as the implantable pacemaker and co-development of the Ad26 COVID vaccine with Johnson & Johnson. BILH includes Harvard-affiliated institutions like Beth Israel Deaconess Medical Center and Joslin Diabetes Center. As a health system rather than a biotech/pharma company developing drugs or devices for regulatory approval stages (e.g., IND/Phase 1), it does not have a traditional clinical pipeline. Beth Israel Lahey Health stands out as one of the largest non-profit integrated health systems in New England focused on delivering comprehensive patient care alongside leading-edge biomedical research through its affiliated academic centers—a key player regionally but not structured like traditional biotech/pharma companies developing proprietary therapeutics or devices.